Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density

Core Insights - Ambry Genetics has announced an enhanced electronic health record (EHR)-integrated breast cancer risk assessment solution aimed at improving patient care and outcomes [1] Company Summary - The new solution integrates with existing EHR systems to streamline the process of assessing breast cancer risk, making it more efficient for healthcare providers [1] - This development reflects Ambry Genetics' commitment to leveraging technology to enhance genetic testing and risk assessment in oncology [1] Industry Summary - The introduction of EHR-integrated solutions is part of a broader trend in the healthcare industry towards digital transformation and personalized medicine [1] - Enhanced risk assessment tools are increasingly important as the demand for precision medicine grows, particularly in oncology [1]